I see some of you are within antibody studies. Here's one I found with data from Clarity IBD, a multisite study led by researchers from the Exeter IBD Research Team, Imperial College London and the University of Hull in the UK.
"Impact of Biologic and Immunomodulatory Therapy on SARS-CoV-2 Infection and Immunity in Patients with Inflammatory Bowel Disease"
"What did the results show?
• Following 2 doses of vaccine, participants
treated with infliximab had antibody levels
that were 4-6 times lower compared to
• By 6 months, antibody levels in infliximab-
treated participants had dropped below a
level that is thought to protect you from
getting a COVID-19 infection.
Direct link to Clarity IBD Newsletterhttps://3e3b9721-aad5-4448-a66f-818ee766a684.filesusr.com/ugd/427e74_f9c3ffd34f8d43d48b55c2a39d09aa03.pdf